Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer. Fujisawa R, et al. Carcinogenesis. 2021 Oct 26;42(10):1239-1249.
Reply. Iwaya T and Nishizuka SS. Gastroenterology. 2021 Jul;161(1):367-368.
Frequent post-operative monitoring of colorectal cancer using individualized ctDNA validated by multi-regional molecular profiling. Yaegashi M, et al. Br J Cancer. 2021 Apr;124(9):1556-1565.
Frequent Tumor Burden Monitoring of Esophageal Squamous Cell Carcinoma With Circulating Tumor DNA Using Individually Designed Digital Polymerase Chain Reaction. Iwaya T, et al. Gastroenterology. 2021 Jan;160(1):463-465.e4.
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA. Sasaki N, et al. PLoS One. 2020 Oct 7;15(10):e0239966.
A Pipeline for ctDNA Detection Following Primary Tumor Profiling Using a Cancer-Related Gene Sequencing Panel. Nishizuka SS, Sato KA, Hachiya T. Methods Mol Biol. 2019;1908:229-241.